| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.105.590083 |
| P698 | PubMed publication ID | 16606792 |
| P50 | author | Lars F. Berglund | Q42710017 |
| P2093 | author name string | Thomas Meinertz | |
| Karsten Sydow | |||
| Tanja K Rudolph | |||
| Volker Rudolph | |||
| Stephan Baldus | |||
| Jason P Eiserich | |||
| Lukas Kubala | |||
| Munif Haddad | |||
| Sonja Schrepfer | |||
| Anna Klinke | |||
| Tobias Deuse | |||
| Wulf D Ito | |||
| Tim Risius | |||
| Denise Lau | |||
| Hanno Klemm | |||
| Katalin Szöcs | |||
| Thomas Heitzer | |||
| Hermann C Reichenspurner | |||
| Mika Roiss | |||
| P433 | issue | 15 | |
| P921 | main subject | bioavailability | Q461809 |
| P304 | page(s) | 1871-1878 | |
| P577 | publication date | 2006-04-10 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase | |
| P478 | volume | 113 |
| Q28741030 | A biomimetic membrane device that modulates the excessive inflammatory response to sepsis |
| Q35139516 | A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma. |
| Q36272300 | Associations between ambient wood smoke and other particulate pollutants and biomarkers of systemic inflammation, coagulation and thrombosis in cardiac patients |
| Q92782717 | Binding of myeloperoxidase to the extracellular matrix of smooth muscle cells and subsequent matrix modification |
| Q37641274 | Biochemical biomarkers of oxidative collagen damage. |
| Q28080960 | Biomarkers of lung injury in cardiothoracic surgery |
| Q36953866 | Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase |
| Q38754143 | CVD and Oxidative Stress |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q47134539 | Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease |
| Q39926807 | Development of an enzyme-linked immunosorbent assay for equine neutrophil elastase measurement in blood: preliminary application to colic cases |
| Q39817652 | Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis |
| Q37632236 | Endothelial function in a mouse model of myeloperoxidase deficiency |
| Q38041505 | Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. |
| Q92634250 | Flow Cytometry-Based Quantification of Neutrophil Extracellular Traps Shows an Association with Hypercoagulation in Septic Shock and Hypocoagulation in Postsurgical Systemic Inflammation-A Proof-of-Concept Study |
| Q34950604 | Heparin use in a rat hemorrhagic shock model induces biologic activity in mesenteric lymph separate from shock |
| Q34119124 | High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis |
| Q33914919 | In women with previous pregnancy hypertension, levels of cardiovascular risk biomarkers may be modulated by haptoglobin polymorphism. |
| Q37326091 | Increased myeloperoxidase in the placenta and circulation of women with preeclampsia |
| Q37698323 | Inflammatory biomarkers and coronary heart disease: from bench to bedside and back. |
| Q36022738 | Interactions between coagulation and complement--their role in inflammation |
| Q90378589 | Iodide modulates protein damage induced by the inflammation-associated heme enzyme myeloperoxidase |
| Q47174275 | LOW MOLECULAR WEIGHT HEPARIN FOR THE PREVENTION OF SEVERE PREECLAMPSIA: WHERE NEXT? |
| Q35384765 | Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure |
| Q42472707 | Markers of Blood Cell Activation and Complement Activation in Factor VIII and von Willebrand Factor Concentrates |
| Q36956650 | Multimarker Risk Stratification in Patients With Acute Myocardial Infarction |
| Q50912369 | Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease. |
| Q36630212 | Myeloperoxidase Nuclear Imaging for Epileptogenesis |
| Q41880909 | Myeloperoxidase deficiency preserves vasomotor function in humans |
| Q85090780 | Myeloperoxidase is not associated with scintigraphic myocardial perfusion abnormalities in type 2 diabetic patients with mild stable anginal complaints |
| Q34072878 | Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina |
| Q35541075 | Myeloperoxidase modulation by LDL apheresis in familial hypercholesterolemia |
| Q37992526 | Myeloperoxidase production by macrophage and risk of atherosclerosis |
| Q38309785 | Myeloperoxidase upregulates endothelin receptor type B expression |
| Q34162955 | Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention |
| Q34545509 | Myeloperoxidase: a therapeutic target for preventing insulin resistance and the metabolic sequelae of obesity? |
| Q35902581 | Nitric oxide-mediated coronary flow regulation in patients with coronary artery disease: recent advances |
| Q38855728 | Old and new applications of non-anticoagulant heparin |
| Q34438220 | Oxidative status imbalance in patients with metabolic syndrome: role of the myeloperoxidase/hydrogen peroxide axis |
| Q36905196 | Oxidative stress and endothelial dysfunction in vascular disease |
| Q38172089 | Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage |
| Q36776259 | Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease |
| Q38095369 | Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role? |
| Q37739378 | Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus |
| Q35165194 | Reactive oxygen species in cardiovascular disease. |
| Q46872925 | Red blood cells serve as intravascular carriers of myeloperoxidase |
| Q64260708 | Renal Intra-Arterial Heparin Flushing for Blood Pressure Control in Refractory Hypertension: A New Method to Salvage the Unsalvageable Renal Artery Stenosis |
| Q64268981 | Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers |
| Q43180799 | Seawater immersion aggravates sciatic nerve injury in rats |
| Q39097080 | Sequential analysis of myeloperoxidase for prediction of adverse events after suspected acute coronary ischemia |
| Q43473309 | Serum myeloperoxidase level predicts reperfusion in patients with myocardial infarction receiving thrombolytic therapy |
| Q30530606 | Targeted subendothelial matrix oxidation by myeloperoxidase triggers myosin II-dependent de-adhesion and alters signaling in endothelial cells |
| Q90449141 | The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Protects Vascular Endothelial Function in Hypercholesterolemic Rats by Inhibiting Myeloperoxidase |
| Q37775189 | The role of activated neutrophils in the early stage of equine laminitis |
| Q37291868 | The role of myeloperoxidase (MPO) for prognostic evaluation in sensitive cardiac troponin I negative chest pain patients in the emergency department |
| Q30240734 | The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture. |
| Q36548164 | The utility of lung epithelium specific biomarkers in cardiac surgery: a comparison of biomarker profiles in on- and off-pump coronary bypass surgery. |
| Q34787028 | Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation |
Search more.